Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Experienced professionals can fix bad scalp micropigmentation with good results.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Bariatric surgery improves health but often causes hair loss and vitamin deficiency.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

People were generally happy with the home light therapy devices for hair loss.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Oral minoxidil can improve hair thickness and a comprehensive treatment approach leads to better alopecia outcomes.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

AGA linked to worse COVID-19 outcomes in men.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.